PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.595
https://www.valueinhealthjournal.com/article/S1098-3015(19)30787-9/fulltext
Title :
PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30787-9&doi=10.1016/j.jval.2019.04.595
First page :
Section Title :
Open access? :
No
Section Order :
10214